212 related articles for article (PubMed ID: 2158036)
1. The oncogenic protein p60v-src has competence activity but does not activate phosphatidylinositol turnover or protein kinase C in Balb/c 3T3 cells.
Han JW; Gaut J; Burstein E; Sadowski H; Young D; Macara IG
Oncogene; 1990 Apr; 5(4):467-74. PubMed ID: 2158036
[TBL] [Abstract][Full Text] [Related]
2. Persistent induction of cyclooxygenase in p60v-src-transformed 3T3 fibroblasts.
Han JW; Sadowski H; Young DA; Macara IG
Proc Natl Acad Sci U S A; 1990 May; 87(9):3373-7. PubMed ID: 2159148
[TBL] [Abstract][Full Text] [Related]
3. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
Kamps MP; Sefton BM
Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
[TBL] [Abstract][Full Text] [Related]
4. Serum-stimulated phosphatidylinositol turnover is enhanced in 3T3 cells with active pp60v-src.
Gray GM; Macara IG
Oncogene; 1989 Oct; 4(10):1213-7. PubMed ID: 2507998
[TBL] [Abstract][Full Text] [Related]
5. p60(v-src) and serum control cell shape and apoptosis via distinct pathways in quail neuroretina cells.
Aouacheria A; Ory S; Schmitt JR; Rigal D; Jurdic P; Gillet G
Oncogene; 2002 Feb; 21(8):1171-86. PubMed ID: 11850837
[TBL] [Abstract][Full Text] [Related]
6. Herbimycin A inhibits the association of p60v-src with the cytoskeletal structure and with phosphatidylinositol 3' kinase.
Hamaguchi M; Xiao H; Uehara Y; Ohnishi Y; Nagai Y
Oncogene; 1993 Mar; 8(3):559-64. PubMed ID: 8382356
[TBL] [Abstract][Full Text] [Related]
7. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.
Lin X; Gelman IH
Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136
[TBL] [Abstract][Full Text] [Related]
8. Mitogenesis by v-Src: fluctuations throughout G1 of classical immediate early AP-1 and mitogen-activated protein kinase responses that parallel the need for the oncoprotein.
Wyke AW; Frame MC; Gillespie DA; Chudleigh A; Wyke JA
Cell Growth Differ; 1995 Oct; 6(10):1225-34. PubMed ID: 8845299
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of the p72-74 RAF-1 kinase in 3T3 fibroblasts expressing ras or src oncogenes.
Reed JC; Yum S; Cuddy MP; Turner BC; Rapp UR
Cell Growth Differ; 1991 May; 2(5):235-43. PubMed ID: 1888699
[TBL] [Abstract][Full Text] [Related]
10. Partial characterization of the mitogenic action of pp60v-src, the oncogenic protein product of the src gene of avian sarcoma virus.
Durkin JP; Whitfield JF
J Cell Physiol; 1984 Aug; 120(2):135-45. PubMed ID: 6086674
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor stimulates protein kinase C in quiescent 3T3 cells without Ca2+ mobilization or inositol phosphate accumulation.
Nånberg E; Morris C; Higgins T; Vara F; Rozengurt E
J Cell Physiol; 1990 May; 143(2):232-42. PubMed ID: 2159012
[TBL] [Abstract][Full Text] [Related]
12. Specific desensitization of the epidermal growth factor receptor by pp60v-src.
Gray GM; Wei CN; Macara IG
J Cell Biochem; 1989 Jul; 40(3):271-8. PubMed ID: 2550486
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
[TBL] [Abstract][Full Text] [Related]
14. Cloning and characterization of a thermolabile v-src gene for use in reversible transformation of mammalian cells.
Maroney AC; Qureshi SA; Foster DA; Brugge JS
Oncogene; 1992 Jun; 7(6):1207-14. PubMed ID: 1375718
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src1.
Uehara Y; Murakami Y; Sugimoto Y; Mizuno S
Cancer Res; 1989 Feb; 49(4):780-5. PubMed ID: 2463877
[TBL] [Abstract][Full Text] [Related]
16. Cell division is required for expression of v-myc transforming properties in chicken embryonic neuroretina cells.
Bechade C; Calothy G
Oncogene; 1991 Dec; 6(12):2311-7. PubMed ID: 1662792
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional repression of fibronectin gene expression in v-src transformation.
Gu H; Oliver N
Exp Cell Res; 1995 Apr; 217(2):428-39. PubMed ID: 7698243
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of metalloproteinase (gelatinase) activity secreted from Rous sarcoma virus-infected cells correlates with transforming activity of src.
Hamaguchi M; Yamagata S; Thant AA; Xiao H; Iwata H; Mazaki T; Hanafusa H
Oncogene; 1995 Mar; 10(6):1037-43. PubMed ID: 7535415
[TBL] [Abstract][Full Text] [Related]
19. [Oncogenic activation of p21(ras) and pp60(c-src) in human colonic Caco-2 cells decreases insulin receptor function and expression through protein kinase C-dependent and independent pathways].
Baron-Delage S; Barbu V; Bertrand F; Chastre E; Lévy P; Gespach C; Capeau J; Cherqui G
Bull Cancer; 1994 Oct; 81(10):882-5. PubMed ID: 7734771
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.
Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Druker BJ; Lydon NB
Cancer Res; 1996 Jan; 56(1):100-4. PubMed ID: 8548747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
